
The best biotech conversations you missed this summer
Episode 215
Summer is a busy time for everyone, guests and listeners alike, so today we're taking stock. This is our Summer Recap — a clips episode pulling together the best moments from conversations you might have missed over the past few months. We'll hear from Randy Teel of Arvinas and Per Lundin of Evox on two very different ways of getting drugs to the brain, and Laurent Lévy of Nanobiotix on outsmarting the liver altogether. We'll meet the founders behind these companies, including Andy Parker of Step Pharma and Gene Mack of Gain Therapeutics, and the unlikely paths that got them there. We'll dig into the science of nonsense mutations with Nerissa Kreher of Alltrna, circular RNA with Lu Gao of Therorna, and a cancer target hiding in human genetics. And we'll close with what these leaders think success actually looks like, years from now. So sit back, and let's revisit some of our favourite moments from the summer. 02:32 Solving the delivery problem 08:39 Founder journeys 15:13 Platform science 24:41 Business, money, and geopolitics 32:28 Looking ahead Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here! Stay updated by subscribing to our newsletter To dive deeper into the topic: Episode 204: The first PROTAC is here. What comes next in protein degradation?
Publisher
Beyond Biotech - the podcast from Labiotech
Published
September 18, 2026
Duration
40 min
Format
Podcast
Category
Issues · Tech News
Source
RSS feed
Host
Labiotech
Beyond Biotech - the podcast from Labiotech
@beyondbiotechthepodcastfroml
#biotechconversations #missed #summer
